ArticleAdvances in therapy2024

A DPC Database Study on the Safety of Atezolizumab/Bevacizumab/Carboplatin/Paclitaxel in Non-small Cell Lung Cancer in Japanese Patients.

Akito Hata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.